flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 GLP therapies have established themselves as kidney-protective in type 2 diabetes and high risk of disease. This new post-hoc analysis of SURPASS-CVOT's kidney shows greater kidney protection with tirzepatide (#mounjaro) Semaglutide in CKD - The

Buddy Up: Exercise with a friend for accountability

We therefore propose that tissue-associated oxidative stress may promote conversion of circulating TTR into dsNNTTR locally within the interstitial compartment, rather than exclusively during intracellular synthesis or processing

Long term pharmacotherapy for obesity and overweight: updated meta-analysis

Heres why you should consider partnering with us on your journey to wellness: Holistic Approach At Five Journeys, we recognize that true wellness encompasses more than just physical health

Raised in a military family, Meighan grew up moving often and experiencing diverse cultures

Granhall C, Donsmark M, Blicher TM, Golor G, Sondergaard FL, Thomsen M, et al